methylprednisolone hemisuccinate has been researched along with Disease Exacerbation in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gluck, C; Hooper, DK; Koziell, A; Moodalbail, D; Okamura, D; Shah, L; Wallace, D; Zaritsky, JJ | 1 |
| Dinh, A; Donzé, C; Hautecoeur, P; Heinzlef, O | 1 |
| Fu, DC; Montgomery, JR | 1 |
| Cheng, AL; Huang, HC; Kuo, SH; Lin, CW | 1 |
| Jin, JP; Link, H; Pashenkov, M; Press, R | 1 |
| Hennigar, RA; Tumlin, JA | 1 |
| Galor, A; Lee, MS | 1 |
| Pipeling, MR; Wigley, FM; Wung, PK | 1 |
| Headley, S; Meduri, GU; Postlethwaite, A; Shelby, M; Stentz, F; Tolley, E | 1 |
| Cheng, AL; Hung, RL; Liu, MY; Uen, WC; Wang, CH; Yeh, KH | 1 |
10 other study(ies) available for methylprednisolone hemisuccinate and Disease Exacerbation
| Article | Year |
|---|---|
LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
Topics: Allografts; Blood Component Removal; Child; Child, Preschool; Combined Modality Therapy; Creatinine; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Infant; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Lipoproteins, LDL; Male; Methylprednisolone Hemisuccinate; Proteinuria; Pulse Therapy, Drug; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2019 |
[To treat or not to treat asymptomatic bacteriuria before methylprednisolone perfusion].
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Asymptomatic Diseases; Bacteriuria; Disease Progression; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Treatment Outcome; Unnecessary Procedures; Urinary Tract Infections | 2015 |
High-dose, rapid-infusion IVIG in postvaccination acute disseminated encephalomyelitis.
Topics: Adult; Central Nervous System; Cerebrospinal Fluid; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Encephalomyelitis, Acute Disseminated; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppression Therapy; Immunotherapy; Magnetic Resonance Imaging; Male; Methylprednisolone Hemisuccinate; Military Personnel; Physical Therapy Modalities; Quadriplegia; Recovery of Function; Smallpox Vaccine; Treatment Outcome; Typhoid-Paratyphoid Vaccines; Vaccines | 2008 |
Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clarithromycin; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Humans; Immunophenotyping; Immunosuppressive Agents; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methotrexate; Methylprednisolone Hemisuccinate; Orbital Neoplasms; Prednisolone; Remission Induction; Rituximab; Vincristine | 2013 |
Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Adult; Chemokine CCL19; Chemokine CCL2; Chemokine CXCL10; Chemokines; Chemokines, CC; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2003 |
Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone Hemisuccinate; Prednisone; Prospective Studies; Proteinuria; Pulse Therapy, Drug; Treatment Outcome | 2004 |
Slowly progressive vision loss in giant cell arteritis.
Topics: Aged, 80 and over; Biopsy; Blindness; Choroid; Disease Progression; Fluorescein Angiography; Giant Cell Arteritis; Glucocorticoids; Humans; Ischemia; Male; Methylprednisolone Hemisuccinate; Temporal Arteries; Visual Acuity | 2006 |
"Still" ill?
Topics: Disease Progression; Glucocorticoids; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Still's Disease, Adult-Onset; Tomography, X-Ray Computed | 2008 |
Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS.
Topics: Adult; Bronchoalveolar Lavage Fluid; Cell Membrane Permeability; Cytokines; Disease Progression; Endothelium; Glucocorticoids; Humans; Interleukins; Methylprednisolone Hemisuccinate; Middle Aged; Pneumonia; Prospective Studies; Respiratory Distress Syndrome; Treatment Outcome | 1995 |
Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Disease Progression; Etoposide; Female; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Pilot Projects; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine | 1998 |